CytoSorbents authorizes up to $20M ATM equity offering of common stock

Cytosorbents Corp

Company authorized offer and sale of up to $20M common stock under Open Market Sale Agreement with Jefferies LLC.
Registration statement on Form S-3 (No. 333-281062) declared effective by SEC on September 30, 2024.
Legal opinion of Morgan Lewis & Bockius LLP on legality of issuance filed as Exhibit 5.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.